DUOBRII FDA approval date
The FDA approved DUOBRII on 25 Apr 2019.
- FDA approval date
- 25 Apr 2019
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as HALOBETASOL PROPIONATE; TAZAROTENE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2019-04-25Day | DUOBRII | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209354", "applicant_as_listed_by_fda": "BAUSCH", "brand_names": ["DUOBRII"], "active_ingredients": ["HALOBETASOL PROPIONATE", "TAZAROTENE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190425", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |